Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: MarketLine (a Datamonitor Company)
$50.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Fosun International Ltd proposes acquisition of 28.146 pct equity interest in Aohong Pharma


Friday, 28 Feb 2014 10:24am EST 

Fosun International Ltd:Entered into the new equity transfer agreement with Xinjiang Boze, Aohong Pharma and Yu, pursuant to which, Fosun Pharmaceutical Industrial shall acquire an aggregate of 28.146pct equity interest in Aohong Pharma from Xinjiang Boze at a consideration of not more than 1,866,079,800 yuan.Says as at the date of this announcement, Fosun Pharmaceutical Industrial held 70pct equity interest in Aohong Pharma.Says upon completion, Fosun Pharmaceutical Industrial will hold 98.146pct equity interest in Aohong Pharma.